Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
KCWPSUKJCKZEAO
|
6.3 | IC50 | 2 | — | |
MCXNJEWRZUGGHR
|
6.3 | Ki | 5 | Yes | |
PHLOAJCAGOSYSY
|
6.3 | IC50 | 2 | — | |
RMFBRVNMUBERNS
|
6.3 | IC50 | 2 | — | |
SCPYANGFILNQRM
|
6.3 | IC50 | 2 | — | |
VFGWASLDLFTQPZ
|
6.3 | Ki | 6 | Yes | |
VSXACAOVGDEFLS
|
6.3 | IC50 | 2 | — | |
VXBAJLGYBMTJCY
|
6.3 | Kd | 34 | Yes | |
XFHCSNRQFQRLHZ
|
6.3 | Ki | 12 | Yes | |
ZSHFRMIXWYVCCL
|
6.3 | Ki | 4 | Yes | |
CLESVRTZYWZTST
|
6.3 | IC50 | 2 | — | |
IRJVSHBVCRPYII
|
6.3 | IC50 | 4 | — | |
NWXGFDVFXJMUDD
|
6.3 | IC50 | 5 | — | |
PEWIXJYBHWXEPB
|
6.3 | Ki | 3 | — | |
RJYLSCSDDDQEPD
|
6.3 | IC50 | 10 | — | |
STWYGLPNRVNBTD
|
6.3 | IC50 | 2 | — | |
VESKGNRSKDNTQM
|
6.3 | IC50 | 2 | — | |
ZUHJPCPWABPZDY
|
6.3 | IC50 | 8 | — | |
FFFWFAUFYUNHEL
|
6.3 | IC50 | 2 | — | |
GWBKUWJEWLWOTH
|
6.3 | IC50 | 3 | — | |
MKHLHLAXBRMALM
|
6.3 | IC50 | 5 | — | |
NANAONFNJKBZQE
|
6.3 | IC50 | 5 | — | |
PGIQQBZIZOOVDG
|
6.3 | IC50 | 2 | — | |
PNVSGLKCKYGCFI
|
6.3 | IC50 | 2 | — | |
SMJXTJQOTKCOEN
|
6.3 | IC50 | 2 | — | |
AXXSVTAXFAAJTE
|
6.3 | IC50 | 2 | — | |
FTQIAAZOFQGUCE
|
6.3 | IC50 | 2 | — | |
PPTPZHKDEWOKFO
|
6.3 | IC50 | 2 | — | |
SDRAETFVRBBLOB
|
6.3 | Kd | 5 | — | |
UCHQCSDTPQKAKL
|
6.3 | IC50 | 9 | Yes | |
FBCBXRZGCIFZMS
|
6.3 | IC50 | 2 | — | |
LBFYQISQYCGDDW
|
6.3 | IC50 | 7 | — | |
VMLGIOLTESMMRK
|
6.3 | IC50 | 2 | — | |
WIOFZLMIWUBUJO
|
6.3 | IC50 | 2 | — | |
ACSYKUPGCXYRRO
|
6.3 | Ki | 26 | — | |
AIMXZBBUVLQOEG
|
6.3 | IC50 | 2 | — | |
AIQDZMUPVYDVLB
|
6.3 | Ki | 48 | — | |
CAFYKPIUWNVPMG
|
6.3 | IC50 | 6 | — | |
FPQHXFMYXQZPSV
|
6.3 | Ki | 23 | — | |
GHMRUNOHAHJNNA
|
6.3 | Ki | 29 | — | |
GWXPHWSUMLUDPO
|
6.3 | Ki | 11 | — | |
HATNHAMXMKJCEI
|
6.3 | Ki | 9 | — | |
HNZBELVVHGZHII
|
6.3 | Ki | 5 | — | |
HVIKNWLSYBPGOG
|
6.3 | IC50 | 8 | — | |
JBRASADWXDKCLJ
|
6.3 | Ki | 22 | — | |
JDIIVNYWTTWCFA
|
6.3 | Ki | 2 | — | |
JJGSOVIZOMZMCS
|
6.3 | Ki | 35 | — | |
LRINYHMQZRENCY
|
6.3 | Ki | 29 | — | |
MDJCUXFFMNEBHG
|
6.3 | Ki | 13 | — | |
OJFKUJDRGJSAQB
|
6.3 | IC50 | 17 | — |